Eddie Williams

Mr. Williams currently serves as the special advisor to the CEO of Ascendis Pharma, Inc., and he served as its interim US Chief Commercial Officer in preparation for its first commercial launch. Prior to his work at Ascendis, Mr. Williams was senior vice president of biopharmaceuticals at Novo Nordisk Inc., where he was responsible for the general management of all aspects of the biotechnology business for the U.S. in three therapeutic areas, including hemophilia. Prior to Novo Nordisk, Mr. Williams was vice president of sales in the Respiratory and Dermatology Business Unit at Novartis Pharmaceuticals Corp., where he ran all sales aspects of the respiratory and dermatology businesses. Before joining Novartis, Mr. Williams held numerous sales and marketing positions of increasing responsibility for more than 20 years at Pharmacia & Upjohn Company (acquired by Pfizer in 2002). Mr. Williams is currently on the Board of Catalyst BioSciences and previously served on the board of Biotechnology Innovation Organization (BIO), the National Sales Network and Basic Supply Company, Inc. Mr. Williams has been recognized as Industry Leader of the Year by the National Hemophilia Foundation, and chaired fundraising for the Boys & Girls Club of Trenton/Mercer County. Mr. Williams earned his B.S. in biology and chemistry from Marshall University.